Personalized tumor-informed circulating tumor DNA analysis in monitoring recurrence following resection of high-risk stage II-III gastrointestinal stromal tumor
机构：[1]Peking University People's Hospital, Beijing, China[2]Burning Rock Biotech, Guangzhou, China[3]Chinese People’s Liberation Army General Hospital, Beijing, China[4]National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China[5]Xuanwu Hospital, Capital Medical University, Beijing, China首都医科大学宣武医院
第一作者机构：[1]Peking University People's Hospital, Beijing, China
推荐引用方式(GB/T 7714)：
Gao Zhidong,Cheng Baosen,Bao Yudi,et al.Personalized tumor-informed circulating tumor DNA analysis in monitoring recurrence following resection of high-risk stage II-III gastrointestinal stromal tumor[J].JOURNAL OF CLINICAL ONCOLOGY.2024,42(16):
APA：
Gao, Zhidong,Cheng, Baosen,Bao, Yudi,Cui, Peng,Du, Haiwei...&Ye, Yingjiang.(2024).Personalized tumor-informed circulating tumor DNA analysis in monitoring recurrence following resection of high-risk stage II-III gastrointestinal stromal tumor.JOURNAL OF CLINICAL ONCOLOGY,42,(16)
MLA：
Gao, Zhidong,et al."Personalized tumor-informed circulating tumor DNA analysis in monitoring recurrence following resection of high-risk stage II-III gastrointestinal stromal tumor".JOURNAL OF CLINICAL ONCOLOGY 42..16(2024)
医学